Literature DB >> 8019288

Tacrine and lecithin in Alzheimer's disease. Patient heterogeneity explains varied response.

R Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019288      PMCID: PMC2540296     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Tacrine in Alzheimer's disease.

Authors:  S A Eagger; R Levy; B J Sahakian
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

2.  Tetrahydroaminoacridine and Alzheimer's disease.

Authors:  E J Byrne; T Arie
Journal:  BMJ       Date:  1994-04-02

3.  Lewy bodies and response to tacrine in Alzheimer's disease.

Authors:  R Levy; S Eagger; M Griffiths; E Perry; M Honavar; A Dean; P Lantos
Journal:  Lancet       Date:  1994-01-15       Impact factor: 79.321

4.  Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.

Authors:  N Maltby; G A Broe; H Creasey; A F Jorm; H Christensen; W S Brooks
Journal:  BMJ       Date:  1994-04-02

5.  A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

Authors:  M Farlow; S I Gracon; L A Hershey; K W Lewis; C H Sadowsky; J Dolan-Ureno
Journal:  JAMA       Date:  1992-11-11       Impact factor: 56.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.